You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康德萊醫械(01501.HK)擬設立兩家基金投資生物醫療器械領域
格隆匯 03-19 18:48

格隆匯3月19日丨康德萊醫械(01501.HK)公佈,於2020年3月19日,公司有條件與懷格健康訂立瑛泰認購意向書,內容有關設立瑛泰基金並對其進行投資以及訂立建議瑛泰合夥協議。

瑛泰基金的普通合夥人及所有有限合夥人的目標出資總額為1.1億元至2億元,而懷格企業(作為普通合夥人)應付的資本承擔將不低於人民幣110萬元及公司(作為有限合夥人)應付的資本承擔將為人民幣5000萬元。瑛泰基金將於中國註冊為一家有限合夥企業,主要目標為對主要於中國醫療器械行業的初創或早期企業的股權、可換股貸款及╱或金融資產進行風險投資。

同日,公司有條件與懷格健康訂立瑞信認購意向書,內容有關設立瑞信基金並對其進行投資以及訂立建議瑞信合夥協議。瑞信基金的普通合夥人及所有有限合夥人的目標出資總額為3億元至4億元,而懷格健康(作為普通合夥人)應付的資本承擔將不低於人民幣300萬元及公司(作為有限合夥人)應付的資本承擔將為人民幣5000萬元。

瑞信基金將於中國註冊為一家有限合夥企業,目標為投資主要於中國醫療器械、醫藥、生物製劑、醫療服務及CRO服務行業實體的股權及專注於投資醫療器械及生物醫藥領域的其他股權基金。

公司稱,設立瑛泰基金的主要目的為對中國醫療器械行業的初創或早期企業的股權、可換股貸款及╱或金融資產進行風險投資。設立瑞信基金的目的為投資於中國醫療器械、醫藥、生物製劑、醫療服務及CRO服務行業實體的股權及專注於投資醫療器械及生物醫藥領域的其他股權基金。

董事會認為,基金投資為公司創造了一個契機,有助公司促進其在醫療器械及其他相關行業的戰略發展、提升其競爭力及鞏固其市場地位。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account